CIRCULATING CELL-FREE DNA (CCFDNA) CONCENTRATIONS MEASURED BY CAPILLARY ELECTROPHORESIS: HIGH COST-EFFECTIVENESS IN DISCRIMINATING DLBCL PATIENTS AND ASSOCIATIONS WITH HIGH TUMOR BURDEN

Introduction: DLBCL is a malignancy with marked clinical, biological and prognostic heterogeneity. Its different outcomes may be predicted by the identification of molecular biomarkers. Therefore, quantification of circulating cell-free DNA (ccfDNA) and circulating tumor DNA (ctDNA) have emerged as...

Full description

Bibliographic Details
Main Authors: LAPC Lage, HF Culler, CO Reichert, KS Oliveira, GG Lima, FA Freitas, RO Costa, D Levy, V Rocha, J Pereira
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Hematology, Transfusion and Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137923008313